Latest episode of our podcast for researchers


Cancer Research Matters is a new podcast from Cancer Research UK featuring some of the incredible researchers behind cancer research.

Cancer Research Matters provokes conversation around cancer science, how it shapes our understanding of the disease and the challenges we face as we develop therapies.

The first series focusses on the 20th anniversary of CRUK – we’ll be winding back the clock on some of the great discoveries and breakthroughs made in the past two decades and asking some leading names where they think we’ll be in another 20 years.

This episode features Professor Sara Zanivan. Sara is based at the Beatson Institute for Cancer where she uses a number proteomics approaches to explore the tumour microenvironment. Her lab also applies their proteomics expertise and capability to develop early detection approaches. Specifically, she is interested in utilising mass-spectrometry to examine how large proteomic changes could be used in the clinic.

She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic.

If you’d rather listen via the podcast site – click here

Further reading on mass-spectrometry and proteomics:

Journal paper:


What do you think about the balance between how we study proteomics and genomics? We’d love to hear your thoughts – please do leave a comment below.

More on this topic


There are no tags

Products You May Like

Articles You May Like

Would You Be Happy as a Doctor? Here’s How to Find Out
Hospital Fired All Employees; Profiting Off the Poor; Long COVID and ME/CFS
Daxor’s BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients
25 counsellor-approved questions to build emotional intimacy in your relationship
Study Confirms Link Between COVID-19 Vaccination And Increased Menstrual Cycle Length

Leave a Reply

Your email address will not be published.